Nancy J Hutson - Net Worth and Insider Trading
Nancy J Hutson Net Worth
The estimated net worth of Nancy J Hutson is at least $457,573 dollars as of 2024-04-26. Nancy J Hutson is the Director of BioCryst Pharmaceuticals Inc and owns about 81,818 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $340,363. Nancy J Hutson is the Director of Clearside Biomedical Inc and owns about 93,000 shares of Clearside Biomedical Inc (CLSD) stock worth over $117,180. Nancy J Hutson is also the Director of Endo International PLC and owns about 49,970 shares of Endo International PLC (ENDPQ) stock worth over $30. Besides these, Nancy J Hutson also holds PhaseBio Pharmaceuticals Inc (PHASQ) . Details can be seen in Nancy J Hutson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nancy J Hutson has not made any transactions after 2023-10-03 and currently still holds the listed stock(s).
Transaction Summary of Nancy J Hutson
Nancy J Hutson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy J Hutson owns 4 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) , Clearside Biomedical Inc (CLSD) , and PhaseBio Pharmaceuticals Inc (PHASQ) among others .
Click here to see the complete history of Nancy J Hutson’s form 4 insider trades.
Insider Ownership Summary of Nancy J Hutson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2023-06-14 | director |
| CLSD | Clearside Biomedical Inc | 2023-10-03 | director |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2021-08-18 | director |
| ENDPQ | Endo International PLC | 2018-11-15 | director |
Nancy J Hutson Latest Holdings Summary
Nancy J Hutson currently owns a total of 4 stocks. Among these stocks, Nancy J Hutson owns 81,818 shares of BioCryst Pharmaceuticals Inc (BCRX) as of June 14, 2023, with a value of $340,363 and a weighting of 74.38%. Nancy J Hutson owns 93,000 shares of Clearside Biomedical Inc (CLSD) as of October 3, 2023, with a value of $117,180 and a weighting of 25.61%. Nancy J Hutson also owns 49,970 shares of Endo International PLC (ENDPQ) as of November 15, 2018, with a value of $30 and a weighting of 0.01%. The other 1 stocks PhaseBio Pharmaceuticals Inc (PHASQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Nancy J Hutson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2023-06-14 | 81,818 | 4.16 | 340,363 |
| CLSD | Clearside Biomedical Inc | 2023-10-03 | 93,000 | 1.26 | 117,180 |
| ENDPQ | Endo International PLC | 2018-11-15 | 49,970 | 0.00 | 30 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2021-08-18 | 4,000 | 0.00 | 0 |
Holding Weightings of Nancy J Hutson
Nancy J Hutson Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy J Hutson has made a total of 4 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 12,866 shares on June 14, 2023, which brought Nancy J Hutson around $103,443.
According to the SEC Form 4 filings, Nancy J Hutson has made a total of 5 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Clearside Biomedical Inc is the acquisition of 10,000 shares on October 3, 2023, which cost Nancy J Hutson around $8,600.
According to the SEC Form 4 filings, Nancy J Hutson has made a total of 0 transactions in Endo International PLC (ENDPQ) over the past 5 years. The most-recent trade in Endo International PLC is the sale of 10,000 shares on November 15, 2018, which brought Nancy J Hutson around $128,300.
More details on Nancy J Hutson's insider transactions can be found in the Insider Trading History of Nancy J Hutson table.Insider Trading History of Nancy J Hutson
- 1
Nancy J Hutson Trading Performance
GuruFocus tracks the stock performance after each of Nancy J Hutson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy J Hutson is 11.24%. GuruFocus also compares Nancy J Hutson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy J Hutson within 3 months outperforms 3 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nancy J Hutson's insider trading performs compared to the benchmark.
Performance of Nancy J Hutson
Average Return
-5.39%
Outperforming Transactions
30%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.63 | 11.24 | 40.33 | -5.39 | -10.28 | 15.49 |
| Relative Return to S&P 500(%) | 6.09 | 2.54 | 31.6 | -17.95 | -19.88 | 1.98 |
Nancy J Hutson Ownership Network
Ownership Network List of Nancy J Hutson
Ownership Network Relation of Nancy J Hutson
Nancy J Hutson Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Nancy J Hutson is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include director & CEO Jon P Stonehouse , Vice President and CCO Charles K Gayer , and Exec Director & Finance - PAO Michael L Jones .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Nancy J Hutson made 1 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net sale of 12,866. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Nancy J Hutson Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy J Hutson. You might contact Nancy J Hutson via mailing address: 64 Montauk Avenue, Stonington Ct 06378.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
